MedTrace Logo

Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers

NCT03112733 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 171

Last updated 2019-02-26

No results posted yet for this study

Summary

This study evaluates the usefulness of serum levels of trefoil factor 3 (TFF3), secreted frizzled related protein 4 (sFRP-4), reactive oxygen species modulator 1 (Romo1) and nuclear factor (NF)-κB as potential diagnostic and prognostic biomarkers in ovarian carcinoma.

Conditions

  • Endometrial Neoplasms
  • Ovarian Neoplasms

Interventions

DIAGNOSTIC_TEST

TFF3, SFRP4, Romo1, NFKB

Blood samples of all participants will be collected.

Sponsors & Collaborators

  • Istanbul University

    collaborator OTHER

  • Ilker Kahramanoglu

    lead OTHER

Principal Investigators

  • Ilker Kahramanoglu · Istanbul University Cerrahpasa Medical Faculty

  • Macit Arvas · Istanbul University Cerrahpasa Medical Faculty

  • Fuat Demirkiran · Istanbul University Cerrahpasa Medical Faculty

  • Tugan Bese · Istanbul University Cerrahpasa Medical Faculty

  • Hasan Turan · Istanbul University Cerrahpasa Medical Faculty

  • Hafize Uzun · Istanbul University Cerrahpasa Medical Faculty

  • Salvatore Giovanni Vitale · University of Messina

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-04
Primary Completion
2018-06-21
Completion
2019-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03112733 on ClinicalTrials.gov